Princeton Global Asset Management LLC Gilead Sciences, Inc. Transaction History
Princeton Global Asset Management LLC
- $568 Million
- Q3 2025
A detailed history of Princeton Global Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 1,291 shares of GILD stock, worth $160,187. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,291
Previous 791
63.21%
Holding current value
$160,187
Previous $87,000
64.37%
% of portfolio
0.03%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...